Liver Cancer

Latest News

FDA Approved
Nivolumab With Ipilimumab Approved by FDA for Use in Hepatocellular Carcinoma

April 11th 2025

The combination therapy can be used as first-line treatment for unresectable or metastatic forms of the cancer.

FDA building | Image Credit: © Tada Images - stock.adobe.com
Second CRL for Rivoceranib/Camrelizumab for Unresectable HCC

March 21st 2025

Top 5 liver cancer content of 2024 image graphic with health icons
Top 5 Most-Viewed Liver Cancer Content for 2024

December 27th 2024

Doctor with human liver anatomy model | Image credit: Jo Panuwat D - stock.adobe.com
Tislelizumab Pushes HCC Field Forward With 2024 NCCN Guideline Category 1 Recommendation

December 1st 2024

Man holding liver illustration - SewcreamStudio - stock.adobe.com
Patients With HCC May Avoid Additional Treatment After Complete Response

November 26th 2024

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo